Sangamo Therapeutics (SGMO) – Hot Corp. News
-
Sangamo Therapeutics (SGMO) Announces Research Evaluation and Option Agreement With Subsidiary of Lilly (LLY) for Novel Engineered Capsids
-
Sangamo Therapeutics (SGMO) Announces Global Collaboration With Novartis (NVS) to Develop Genomic Medicines for Autism and Other Neurodevelopmental Disorders
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to SGMO Stock Lookup